TAM
PBE icon

Trillium Asset Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Trillium Asset Management’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,935
Closed -$215K – 243
2018
Q2 		$215K Buy
+3,935
New +$200K 0.01% 233
2018
Q1 		– Sell
-6,795
Closed -$320K – 241
2017
Q4 		$320K Sell
6,795
-127
-2% -$5.95K 0.02% 205
2017
Q3 		$346K Hold
6,922
– – 0.02% 198
2017
Q2 		$316K Hold
6,922
– – 0.02% 201
2017
Q1 		$293K Sell
6,922
-596
-8% -$25K 0.02% 199
2016
Q4 		$292K Hold
7,518
– – 0.02% 200
2016
Q3 		$315K Sell
7,518
-19,953
-73% -$819K 0.02% 195
2016
Q2 		$1.02M Sell
27,471
-110,264
-80% -$4.32M 0.07% 166
2016
Q1 		$5.27M Buy
137,735
+4,380
+3% +$170K 0.35% 97
2015
Q4 		$6.74M Buy
133,355
+1,680
+1% +$83K 0.46% 84
2015
Q3 		$6.02M Buy
131,675
+3,795
+3% +$212K 0.42% 87
2015
Q2 		$7.46M Buy
127,880
+1,576
+1% +$90.1K 0.48% 81
2015
Q1 		$6.96M Buy
126,304
+2,274
+2% +$123K 0.45% 89
2014
Q4 		$6.23M Sell
124,030
-3,411
-3% -$167K 0.42% 97
2014
Q3 		$5.89M Sell
127,441
-10,897
-8% -$491K 0.51% 82
2014
Q2 		$6.05M Sell
138,338
-16,862
-11% -$683K 0.52% 80
2014
Q1 		$6.46M Buy
155,200
+10,015
+7% +$429K 0.61% 64
2013
Q4 		$5.38M Buy
145,185
+3,451
+2% +$124K 0.53% 82
2013
Q3 		$4.97M Buy
141,734
+2,631
+2% +$87.1K 0.55% 79
2013
Q2 		$4.02M Buy
+139,103
New +$3.96M 0.5% 80

Other funds holding PBE

ACM
Arlington Capital Management Arlington Heights, Illinois $161M AUM 38.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CAS
Cue Advisory Services Phoenix, Arizona $167M AUM 18.62% 1-Year Est. Return
AFM
Abbot Financial Management Andover, Massachusetts $239M AUM 27.19% 1-Year Est. Return

Trillium Asset Management's PBE Position: Q3 2018 in Review

Trillium Asset Management sold out of Invesco Biotechnology & Genome ETF (PBE) in Q3 2018, closing a stake of 3,935 shares — an estimated $215K sold.

Trillium Asset Management first reported a position in PBE in Q2 2013 and held it in 20 quarters. The position peaked at $7.46M in Q2 2015. 74 funds tracked by Wall St. Rank hold PBE as of Q3 2018.

  • Trillium Asset Management reported no remaining Invesco Biotechnology & Genome ETF position as of Q3 2018 after selling out during the quarter.
  • Trillium Asset Management sold 3,935 Invesco Biotechnology & Genome ETF shares in Q3 2018, an estimated $215K.
  • Trillium Asset Management first reported a position in Invesco Biotechnology & Genome ETF in Q2 2013 and held it in 20 quarters.
  • Trillium Asset Management's Invesco Biotechnology & Genome ETF position peaked at $7.46M in Q2 2015.
  • 74 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2018.

Based on Trillium Asset Management's 13F filing for Q3 2018, filed 9 Nov 2018.